46.46.Z - Wholesale trade of pharmaceutical and medical products
49.41.Z - Road freight transport
64.19.Z - Other monetary intermediation
64.91.Z - Financial leasing
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
70.22.Z - Head office activities and management consultancy
73.12.B - Advertising through mass media
73.12.C - Advertising through mass media
73.12.D - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,5 | 1,1 | 10,5 | 824 |
EBITDA | 8,1 | 7,6 | 19,4 | 154,9 |
Short time liabilities | 45,5 | 56,5 | 104,6 | 85,3 |
Equity capital | 37,2 | 36,7 | 46,5 | 26,7 |
Operating profit (EBIT) | 6,7 | 6,4 | 17,8 | 178 |
Assets | 122,2 | 129,2 | 154,1 | 19,3 |
Net profit (loss) | 3,4 | 1 | 10,3 | 952,6 |
Cash | 11,6 | 8 | 3,2 | -59,6 |
Liabilities and provisions for liabilities | 85 | 92,5 | 107,6 | 16,4 |
Net income from sale | 126,8 | 164,4 | 218,9 | 33,1 |
Working assets | 107,2 | 114,4 | 140,4 | 22,8 |
Depreciation | 1,4 | 1,2 | 1,6 | 32,6 |
% | % | % | p.p. | |
Profitability of capital | 9,2 | 2,7 | 22,2 | 19,5 |
Equity capital to total assets | 30,5 | 28,4 | 30,2 | 1,8 |
Gross profit margin | 2 | 0,7 | 4,8 | 4,1 |
EBITDA Margin | 6,4 | 4,6 | 8,9 | 4,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 131 | 125 | 175 | 50 |
Current financial liquidity indicator | 2.319870710372925 | 2.01914381980896 | 1.3358986377716064 | -0,7 |
Net dept to EBITDA | 4.97541618347168 | 6.681741714477539 | 2.5653185844421387 | -4,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane